Martin Dow has three major business segments which foster our corporate vision of becoming a leading pharmaceutical company of the region ensuring accessibility of high quality healthcare products to the society. These segments are strategically aligned to bring innovative, high-quality and affordable medicines including:
Martin Dow develops and markets innovative medicines to enhance health outcomes for patients and health care providers. We are at the forefront of development and commercialization of primary care and specialty medicines comprising of different therapeutic segments and specialties:
Martin Dow Ltd. has continued to focus towards the development of the company not only through the provision of quality centric medicines and services, but it has also taken up the responsibility to provide the same quality to a greater variety of its customers. For that purpose, Martin Dow is incessantly endeavoring to enter into new markets.
Martin Dow’s enabling mindset and pro-active approach has recently enabled it to enter the following markets:
- Nutraceuticals and Dietary supplements